Lavelle Erin
CIK 0001737613
COO & CFODirector
Filings
5
Latest May 1, 2026
Issuers covered
4
Showing
5 of 5
Page 1
Track record
Realized signed returns on open-market buys and sales
No scored trades yet for Lavelle Erin. Track record appears once open-market purchases or sales reach the +30 day horizon.
Issuers
Companies where Lavelle Erin has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| NGNE | Neurogene Inc. | 2 | Jun 9, 2023 |
| AVTE | Aerovate Therapeutics, Inc. | 1 | May 1, 2025 |
| AVLN | Avalyn Pharma Inc. | 1 | May 1, 2026 |
| ELYM | Eliem Therapeutics, Inc. | 1 | Jan 31, 2022 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|